UCLA Medical Center Hematology and Medical Oncology

Topics

• Acute Myeloid Leukemia Research 368
• Cancer Immunotherapy and Biomarkers 356
• HER2/EGFR in Cancer Research 281
• Hematopoietic Stem Cell Transplantation 230
• Sarcoma Diagnosis and Treatment 214
• Cancer survivorship and care 212
• Advanced Breast Cancer Therapies 210
• CAR-T cell therapy research 207
• Chronic Myeloid Leukemia Treatments 173
• Lung Cancer Treatments and Mutations 165
• Melanoma and MAPK Pathways 165
• Lymphoma Diagnosis and Treatment 159

Most cited

1. Hepatocellular carcinoma.

   Nature reviews. Disease primers · 2021 · 5,588 citations · Richard S. Finn

2. Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.

   The New England journal of medicine · 2024 · 923 citations · Alexandra Drakaki

3. Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma.

   Journal of hepatology · 2022 · 1,506 citations · Richard S. Finn

4. Immunotherapies for hepatocellular carcinoma.

   Nature reviews. Clinical oncology · 2022 · 1,520 citations · Richard S. Finn

5. Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial.

   Lancet (London, England) · 2023 · 986 citations · Richard S. Finn

6. Cancer treatment and survivorship statistics, 2025.

   CA: a cancer journal for clinicians · 2025 · 307 citations · Patricia A. Ganz